
January 17-22, 2010
Day 1 Sessions |
Workshop Introduction - Polly Sager |
Introduction to Epidemiology – Kenneth Schulz |
The Role of Biostatistics – Mario Chen |
Protecting Human Participants in Research: Historical and Ethical Perspectives – Jeremy Sugarman |
Ethics in the Design of Clinical Research – Jeremy Sugarman |
Primary Research Question and Definition of Endpoints – Mario Chen |
Writing a Protocol – Deborah Hilgenberg |
Day 2 Sessions |
ICH GCP– Michelle Immelman |
The Informed Consent Process – Jeremy Sugarman |
Role of Institutional Review Boards (IRBs) – Jeremy Sugarman |
Essential Documents and Source Documents – Michelle Immelman |
Safety Oversight Guidelines – Mario Chen |
Practical Considerations for Fielding a Research Study – Deborah Hilgenberg |
Day 3 Sessions |
Analytic Study Design – Kenneth Schulz |
Sample Size Determination – Mario Chen |
Day 4 Sessions |
Critical Elements of Randomized Trials – Kenneth Schulz |
Development of Analysis Plans – Mario Chen |
Data Management Plans – Patrick Murphy |
GCP Requirements for IRBs – Michelle Immelman |
Lab Samples and Tracking – Patrick Murphy |
SOPs, WIs and Forms – Patrick Murphy |
Day 5 Session |
Quality Control/Quality Assurance – Michelle Immelman |
Retention in Prospective Studies– Kenneth Schulz |
Case Report Form (CRF) Design - Patrick Murphy |
GCP Requirement for Informed Consents – Michelle Immelman |
Understanding Adverse Events – Deborah Hilgenberg |
| If Research is Not Published, It Did Not Happen – Ken Schulz |
Clinical Site Monitoring - Michelle Immelman |
What is the ICSSC? – Michelle Immelman |
Other Materials |
NIAID Oversight of Clinical Research & Funding Opportunities-NIH Clinical Terms of Award and Funding Opportunities - Polly Sager |
Supplemental Materials (6.5MB file) |